Statistics for ARS Pharmaceuticals, (id:6523 SPRY)

Valuation metrics

Market cap

1.36B

Enterprise value

1.09B

Trailing P/E (ttm)

-24.56

Forward P/E

-18.42

PEG ratio

-18.42

Price/Sales (ttm)

529.83

Price/Book (mrq)

6.76

Enterprise Value/Revenue

425.92

Enterprise Value/EBITDA

-18.10

Overview

Shares outstanding

97.19M

Float

44.99M

Shares short

12.60M

% Held by insiders

0.23%

% Held by institutions

0.68%

Average volume (10 days)

1.68M

Average volume (90 days)

Price summary

52-Week low

4.65

52-Week high

18.51

52-Week change

66.00%

Beta

1.00

50-Day moving average

14.76

200-Day moving average

10.93

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-1,051.64%

Operational effectiveness

Return on assets

-16.22%

Return on equity

-22.41%

Income statement

Revenue (ttm)

0.03

Revenue per share (ttm)

0.03

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-60,444,000.00

Net income to common (ttm)

-49,104,000.00

Diluted EPS (ttm)

-0.50

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

204.62M

Total cash per share (mrq)

2.11

Total debt (mrq)

102.00K

Total Debt/Equity (mrq)

0.05

Current ratio (mrq)

1.26K%

Book value per share (mrq)

2.07

Cash flow

Cash flow statement

-45,861,000.00

Levered free cash flow (LFCF)

-31,671,250.00